InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: trading.jeff post# 45878

Thursday, 11/29/2018 8:49:22 AM

Thursday, November 29, 2018 8:49:22 AM

Post# of 48316
TAVO mono is significant evidence that Oncosec therapy works without a checkpoint. Big Pharma will take notice... this is concrete final data and it stacks up well with checkpoint monotherapy....without toxic side effects. Just wait til next year when the PIIM multi-gene construct rolls out. If Oncosec can produce greater than 30% BORR with no side effects they could be on the road to displacing checkpoint therapy.....so now who is going to jump in and buyout ONCS tech to gain control?